Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

CapEx to Depreciation

0.29×

Quarterly · Period ending: Jun 30, 2026

LCTX CapEx to Depreciation

Latest reported0.29×period endingJun 30, 2026

Latest reported0.29×period endingJun 30, 2026

LCTX Quarterly CapEx/Depreciation (0.00× → 0.29×)

Latest values, visible window

High-resolution chart · PNG

LCTX capex to depreciation history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock CapEx to Depreciation — Quarterly
Period ending	CapEx to Depreciation
Jun 30, 2001	0.2195×
Mar 31, 2001	0.0759×
Dec 31, 2000	0×
Sep 30, 2000	0.2371×
Jun 30, 2000	1.1501×
Mar 31, 2000	0.411×
Dec 31, 1999	0×
Sep 30, 1999	0×
Jun 30, 1999	0×
Mar 31, 1999	0×
Sep 30, 1998	0×
Jun 30, 1998	0×
Mar 31, 1998	0×
Dec 31, 1997	0×
Sep 30, 1997	0×
Jun 30, 1997	0×
Mar 31, 1997	0×
Dec 31, 1996	0×
Sep 30, 1996	0×
Jun 30, 1996	0×
Mar 31, 1996	0×
Dec 31, 1995	0×
Sep 30, 1995	0×
Jun 30, 1995	0×
Mar 31, 1995	0×
Dec 31, 1994	0×
Sep 30, 1994	0×
Jun 30, 1994	0×
Mar 31, 1994	0×
Dec 31, 1993	0×
Sep 30, 1993	0×
Jun 30, 1993	0×
Mar 31, 1993	0×
Dec 31, 1992	0×
Sep 30, 1992	0×
Jun 30, 1992	0×
Mar 31, 1992	0×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.